Cecilia Allievi

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib

Roberto Piva, Bruce Ruggeri, Michael Williams et al. · Blood · 2007 · 253 citations · Full text

Medicine, Oncology, Pharmacology +9

Discovery of a Potent, Selective, and Orally Active Proteasome Inhibitor for the Treatment of Cancer

Bruce D. Dorsey, Mohamed Iqbal, Sankar Chatterjee et al. · Journal of Medicinal Chemistry · 2008 · 147 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Biosynthesis of salsolinol, a tetrahydroisoquinoline alkaloid, in healthy subjects

P. Dostert, M. Strolin Benedetti, V. Bellotti et al. · Journal of Neural Transmission · 1990 · 74 citations

Pharmacy, Biochemistry, Pharmacology +7

Phase II study of BBR 3464 as treatment in patients with sensitive or refractory small cell lung cancer

Thomas A. Hensing, Nasser H. Hanna, Heidi H. Gillenwater et al. · Anti-Cancer Drugs · 2006 · 70 citations

Medicine, Oncology, Pharmacology +16

Cytochrome P-450-Mediated Metabolism of the Individual Enantiomers of the Antidepressant Agent Reboxetine in Human Liver Microsomes

Larry C. Wienkers, Cecilia Allievi, M J Hauer et al. · Drug Metabolism and Disposition · 1999 · 70 citations

Medicine, Pharmacokinetics, Pharmacology +17